Development of Phosphatized Calcium Carbonate Biominerals as Bioactive Bone Graft Substitute Materials, Part II: Functionalization with Antibacterial Silver Ions
Source abstract
Abstract
Porous calcium phosphate (CaP) materials as bone graft substitutes can be prepared from Ca carbonate biomineral structures by hydrothermal conversion into pseudomorphic CaP scaffolds. The present study aims at furnishing such phosphatized Ca carbonate biomineral (PCCB) materials with antibacterial Ag ions in order to avoid perisurgical wound infections. Prior to this study, PCCB materials with Mg and/or Sr ions incorporated for stimulating bone formation were prepared from coral skeletons and sea urchin spines as starting materials. The porous PCCB materials were treated with aqueous solutions of Ag nitrate with concentrations of 10 or 100 mmol/L, resulting in the formation of Ag phosphate nanoparticles on the sample surfaces through a replacement reaction. The materials were characterized using scanning electron microscopy (SEM) energy-dispersive X-ray spectroscopy (EDS) and X-ray diffractometry (XRD). In contact with Ringer`s solution, the Ag phosphate nanoparticles dissolved and released Ag ions with concentrations up to 0.51 mg/L, as shown by atomic absorption spectroscopy (AAS) analyses. In tests against Pseudomonas aeruginosa and Staphylococcus aureus on agar plates, antibacterial properties were similar for both types of Ag-modified PCCB materials. Concerning the antibacterial performance, the treatment with AgNO3 solutions with 10 mmol/L was almost as effective as with 100 mmol/L.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Titanium Alloys Microstructure and Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Applied Geosciences, Technische Universität Darmstadt, 64287 Darmstadt, Germany
Department of Biology, Technische Universität Darmstadt, 64287 Darmstadt, Germany
Funding
Deutsche Forschungsgemeinschaft
References (62)
Show source-provided references
1. Bioresorbable bone graft substitutes of different osteoconductivities: A histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric acid)-based cement implants in rats10.1016/S0142-9612(99)00179-9 ↗
2. Iliac crest autogenous bone grafting: Donor site complications
3. Autogenous iliac crest bone graft—Complications and functional assessment10.1097/00003086-199706000-00011 ↗
4. Iliac crest bone-graft harvest donor site morbidity—A statistical evaluation10.1097/00007632-199505000-00012 ↗
5. Calcium Phophate-Based Osteoinductive Materials10.1021/cr800427g ↗
6. Bioceramics of calcium orthophosphates10.1016/j.biomaterials.2009.11.050 ↗
7. Kokubo, T. (2008). Osteoinduction and its evaluation. Bioceramics and Their Clinical Applications, CRC Press.10.1533/9781845694227 ↗
8. Kokubo, T. (2008). Osteoconduction and its evaluation. Bioceramics and Their Clinical Applications, CRC Press.10.1533/9781845694227 ↗
9. Application of porous ceramics for the attachment of load bearing internal orthopedic applications10.1002/jbm.820050613 ↗
10. Attachment of prostheses to musculoskeletal system by tissue ingrowth and mechanical interlocking10.1002/jbm.820070303 ↗
11. Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis10.1093/oxfordjournals.jbchem.a021589 ↗
12. Quantification of bone ingrowth within bone-derived porous hydroxyapatite implants of varying density10.1023/A:1008900127475 ↗
13. Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo10.1002/jbm.1222 ↗
14. Microporosity affects bioactivity of macroporous hydroxyapatite bone graft substitutes
15. Bioceramic bone graft substitutes: Influence of porosity and chemistry10.1111/j.1744-7402.2005.02020.x ↗
16. Influence of the porosity of hydroxyapatite ceramics on in vitro and in vivo bone formation by cultured rat bone marrow stromal cells10.1007/s10856-006-8232-z ↗
17. Epple, M. (2003). Biomaterialien und Biomineralisation—Eine Einführung für Naturwissenschaftler, Mediziner und Ingenieure, Teubner.10.1007/978-3-322-80035-0 ↗
18. Biomaterials for bone filling: Comparisons between autograft, hydroxyapatite and one highly purified bovine xenograft
19. Comparative study of the osteoinductive properties of bioceramic, coral and processed bone-graft substitutes10.1016/0142-9612(95)93584-Z ↗
20. Ceramic anterior spinal fusion—Biologic and biomechanical comparison in a canine model10.1097/00007632-199612010-00003 ↗
21. Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis10.1002/jor.1100140304 ↗
22. Biological reactions to calcium phosphate ceramic implants—Results of animal experiments
23. Biodegradation behavior of various calcium-phosphate materials in bone tissue10.1002/jbm.820170505 ↗
24. Calcium-phosphate ceramics as hard tissue prosthetics10.1097/00003086-198106000-00037 ↗
25. Tri-calcium phosphate ceramics and allografts as bone substitutes for spinal fusion in idiopathic scoliosis as bone substitutes for spinal fusion in idiopathic scoliosis: Comparative clinical results at four years
26. Kokubo, T. (2008). Tricalcium phosphate/hydroxyapatite biphasic ceramics. Bioceramics and Their Clinical Applications, CRC Press.
27. Hydroxyapatite formed from coral skeletal carbonate by hydrothermal exchange10.1038/247220a0 ↗
28. Hydrothermal conversion of coral into hydroxyapatite10.1016/S1044-5803(01)00154-1 ↗
29. Conversion of sea urchin spines to Mg-substituted tricalcium phosphate for bone implants10.1016/j.actbio.2007.03.009 ↗
30. Combined hydrothermal conversion and vapor transport sintering of Ag-modified calcium phosphate scaffolds10.1111/jace.12137 ↗
31. Coralline bone graft substitutes10.1016/S0030-5898(05)70113-9 ↗
32. Is there a role of coral bone substitutes in bone repair?10.1016/j.injury.2016.10.025 ↗
33. Effect of magnesium on lipid-induced calcification: An in vitro model for bone mineralization10.1007/BF02408533 ↗
34. Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating WNT/catenin signalling10.1002/stem.646 ↗
35. Optimizing bone matabolism in osteoporosis: Insight into the pharmacologic profile of strontium ranelate10.1007/s00198-002-1344-5 ↗
36. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells10.1016/j.metabol.2003.10.022 ↗
37. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite10.1023/A:1008811501734 ↗
38. Preparation of silver/hydroxyapatite nanocomposite spheres10.1016/j.powtec.2007.07.034 ↗
39. Synthesis and antimicrobial activity of a silver-hydroxyapatite nanocomposite10.1155/2009/498505 ↗
40. Hydroxyapatite supported antibacterial Ag3PO4 nanoparticles10.1039/c0jm01500h ↗
41. Bioactive delivery systems for the slow-release of antibiotics: Incorporation of Ag+ ions into micro-porous hydroxyapatite coatings10.1016/0167-577X(95)00059-3 ↗
42. Antibacterial effects of Ag-HAp thin films on alumina substrates10.1016/S0040-6090(98)00956-0 ↗
43. Anti-bacterial and cytotoxic properties of plasma sprayed silver-containing HA coatings10.1007/s10856-008-3529-8 ↗
44. Calcium phosphate coating containing silver shows high antibacterial activity and low cytotoxicity and inhibits bacterial adhesion10.1016/j.msec.2009.09.015 ↗
45. Functionally graded hydroxyapatite coatings doped with antibacterial components10.1016/j.actbio.2009.12.002 ↗
46. Antibacterial nanosized silver substituted hydroxyapatite: Synthesis and characterization10.1002/jbm.a.30958 ↗
47. Densification, phase stability and in vitro biocompatibility property of hydroxyapatite-10 wt% silver composites10.1007/s10856-009-3939-2 ↗
48. Determination of antibacterial properties and cytocompatibility of silver-loaded coral hydroxyapatite10.1007/s10856-010-4101-x ↗
49. Preparation and characterization of beta-tricalcium phosphate co-doped with monovalent and divalent antibacterial metal ions10.1016/j.actbio.2009.04.010 ↗
50. Incorporation of reactive silver-tricalcium phosphate nanoparticles into polyamide 6 allows preparation of self-disinfecting fibers10.1002/pen.21779 ↗
51. Synthesis and characterization of functional gradient materials using Indian corals10.1023/A:1008915510976 ↗
52. Effect of TiO2-Ag2O additives on the formation of calcium phosphate based functionally graded bioceramics10.1016/S0142-9612(00)00092-2 ↗
53. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis10.1128/AEM.71.11.7589-7593.2005 ↗
54. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
55. Controlling ion release from bioactive glass foam scaffolds with antibacterial properties10.1007/s10856-006-0434-x ↗
56. Mechanism of silver sulfadiazine action on burn wound infections10.1128/AAC.5.6.582 ↗
57. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth10.1016/j.watres.2008.02.021 ↗
58. Sethmann, I., Luft, C., and Kleebe, H.-J. (2018). Development of phosphatized calcium carbonate biominerals as bioactive bone graft substitute materials, part I: Incorporation of magnesium and strontium ions. J. Funct. Biomater., submitted.10.3390/jfb9040069 ↗
59. Isomorphous substitutions in β-tricalcium phosphate: The different effects of zinc and strontium10.1016/S0162-0134(96)00219-X ↗
60. Gustafsson, J.P. (2016). Visual MINTEQ, KTH, SEED. version 3.1.
61. Solubility of silver sulfadiazine in physiological media and relevance to treatment of thermal burns with silver sulfadiazine cream10.1093/clinchem/41.1.87 ↗
62. The outer membrane of Gram-negative bacteria10.1016/S0065-2911(08)60208-8 ↗